Crossmark

Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)

Crossref DOI link: https://doi.org/10.1038/s41416-024-02731-6

Published Online: 2024-06-12

Published Print: 2024-08-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aronson, S. Lot http://orcid.org/0000-0001-7262-1015
Walker, Cédric

Thijssen, Bram http://orcid.org/0000-0003-1562-2649
van de Vijver, Koen K. http://orcid.org/0000-0002-2026-9790
Horlings, Hugo M. http://orcid.org/0000-0003-4782-8828
Sanders, Joyce http://orcid.org/0000-0002-0551-7813
Alkemade, Maartje

Koole, Simone N.

Lopez-Yurda, Marta http://orcid.org/0000-0003-3678-3222
Lok, Christianne A. R.

,

van Driel, W. J.

Hermans, H. M.

van Leeuwen, J. H. Schagen

Schreuder, H. W. R.

van Gent, M. D. J. M.

van Ham, M. A. P. C.

Arts, H. J. G.

van Dam, P. A.

Vuylsteke, P.

Rottenberg, Sven

van Rheenen, Jacco http://orcid.org/0000-0001-8175-1647
Sonke, Gabe S.

van Driel, Willemien J. http://orcid.org/0000-0003-2246-1994
Kester, Lennart A.

Hahn, Kerstin http://orcid.org/0000-0003-3602-4234
Funding

Funding for this research was provided by:

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030M_219453)

Josef Steiner Cancer Research Foundation

Institutional funds
License Information

Text and Data Mining valid from 2024-06-12

Version of Record valid from 2024-06-12
More Information

Article History

Received: 19 December 2023

Revised: 14 May 2024

Accepted: 17 May 2024

First Online: 12 June 2024

Competing interests

: KKVdV has served on advisory boards for Exact Sciences and AstraZeneca. HMH received honoraria from Roche Diagnostics BV. GSS has received institutional research support from Merck Sharp & Dohme, Agendia, AstraZeneca, Roche, and Novartis, and consulting fees from Biovica and Seagen. KH is a former employee at the Netherlands Cancer Institute and is currently working for Roche, Pharmaceutical Sciences, Basel, Switzerland. The research for this project was conducted in her position of researcher at the NKI. The remaining authors declare no competing interests.

: The protocol was approved by the local ethics committee at each of the participating centres. All patients provided written informed consent prior to enrolment. This study was performed in accordance with the Declaration of Helsinki.

: Not applicable.

Document is current

Any future updates will be listed below